Saitama, Japan

Tomohiro Sato

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Riken Corporation, The University of Tokyo. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Sato. Retrieved from https://idiyas.com/inventor/tomohiro-sato-l75h4qm8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Tomohiro Sato from Saitama, Japan

Introduction

Tomohiro Sato is an esteemed inventor based in Saitama, Japan, recognized for his significant contribution in the field of biochemical innovations. With a noteworthy patent to his name, Sato has made strides in creating compounds that have the potential to transform therapeutic approaches to various diseases.

Latest Patents

Sato holds a patent for a BMP-signal-inhibiting compound. This invention focuses on novel small-molecule compounds that specifically antagonize BMP (Bone Morphogenetic Protein) signal pathways. These compounds are pivotal in modulating cell growth, differentiation, proliferation, and apoptosis, making them beneficial in treating diseases related to BMP signaling, including inflammation, cardiovascular diseases, hematopoietic diseases, cancer, osteodystrophia, and notably, fibrodysplasia ossificans progressiva. Thus, this innovation presents a valuable pharmacological agent for regulating cellular processes essential for health.

Career Highlights

Throughout his illustrious career, Tomohiro Sato has contributed significantly to scientific research and development. He has worked with reputable organizations, including Riken Corporation and The University of Tokyo, where he honed his expertise in biochemistry and pharmaceutical sciences. His work has not only advanced scientific knowledge but has also paved the way for potential clinical applications.

Collaborations

Sato has collaborated with prominent colleagues in the field, including Yoshinobu Hashizume and Katsuhiko Sekimata. These collaborations have enriched his research endeavors, fostering an environment of innovation and exploration in the scientific community.

Conclusion

Tomohiro Sato's pioneering work in developing BMP-signal-inhibiting compounds exemplifies the critical role that inventors play in advancing medical science. His innovative contributions have the potential to address complicated health issues, highlighting the importance of continued research and development in biochemistry. As he progresses in his career, the impact of Sato's inventions will undoubtedly resonate within the healthcare landscape, offering hope for effective treatments to many diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…